Application for bio-equivalent test doubled in May.

Published: 2004-05-20 06:57:00

Updated: 2004-05-20 06:57:00

The number of application for the bio-equivalent test in May rose rapidly amid which bio-equivalent test shall be obligated to submit for any generic product registration from the 2nd half of this year but the price controls up to 80% out of the original drug could be no longer effected. As of M...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK